Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


Grant Creates Center for Maternal, Pediatric Precision Therapeutics


 
Prince Kannankeril, MD, MSCI

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health (NIH) to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics (MPRINT).

Vanderbilt will join University of California San Diego, Ohio State University, and Indiana University to form the new Maternal and Pediatric Precision in Therapeutics Hub. These four institutions, funded by the NIH, will work together to serve as a national resource to expand knowledge and expertise in maternal and pediatric pharmacology.


Sara Van Driest, MD, PhD

Co-directed by Prince Kannankeril, MD, MSCI, professor of Pediatrics, and Sara Van Driest, MD, PhD, associate professor of Pediatrics and Medicine, from Vanderbilt's Department of Pediatrics, the Vanderbilt center aims to study how to improve the implementation of precision therapeutics, or personalized medicine, for pregnant women and children and explore long-term outcomes for the two populations.

"Maternal and pediatric precision therapeutics is an understudied area," said Kannankeril, who is a clinical pediatric cardiologist and electrophysiologist. "We want to be able to give pregnant women and children the right drug, at the right dose, at the right time -- not the drug that seems to be the right dose for the majority of the population. There are things specific to us as individuals -- age, genetic background, pregnancy, breastfeeding -- that may make a drug act differently in one body compared to others."

Vanderbilt's MPRINT center will launch with two simultaneous projects. One, led by Van Driest and Digna Velez Edwards, PhD, associate professor of Obstetrics, will seek to close gaps in pharmacogenomics applications for women and children. A part of this work will be to perform clinical PREDICT (Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment) testing to help guide the prescribing of commonly used medications, such as antidepressants and pain control medicines.

Historically, pharmacogenetics -- how differences in one's genes affect response to a medication -- is not well studied in pregnant women and children, and the team hopes to gain better insights to build on health care's increasing focus to personalize drug therapies and create individual treatment plans.

The second project, led by Stephen Patrick, MD, MPH, associate professor of Pediatrics and Health Policy, will bring together electronic health records and additional databases to evaluate the effectiveness of medications used to treat opioid use disorder in pregnant women. The project will shed light on how these treatments impact long-term outcomes for the mother and baby.

Both of the Vanderbilt projects will be supported by the Phenotyping Core, led by Wei-Qi Wei, MD, PhD, assistant professor of Biomedical Informatics, who has expertise in using electronic health records and techniques like machine learning to better understand response to medications.

Van Driest has long worked on precision medicine and personalized care in pediatrics using large data sources like electronic health medical records and DNA sequencing to predict and improve children's response to medications.

The MPRINT Hub, she said, will serve as a network to help evaluate and potentially influence therapeutics for both women during pregnancy and children throughout childhood.

"During childhood and during pregnancy, the patient changes an enormous amount. At the same time, we have very little data to guide how we should incorporate those changes into our prescribing," said Van Driest. "We're really excited to be able to make some strides forward in understanding how these tremendous changes during pregnancy and during childhood guide our medication choices."

The MPRINT grant also builds off the foundational work already in place with the existing Center for Pediatric Precision Medicine, led by Kannankeril and Van Driest.

That initiative launched in 2020 to support evidence-based, individualized diagnosis and treatment approaches for children.

With the MPRINT grant funding, the center also will have a focus on training and mentoring, and each year will support early career investigators in research projects around genomics and precision medicine.

The Maternal and Pediatric Precision in Therapeutics Center of Excellence at Vanderbilt is supported by funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant P50HD106446-01).

 
Share:

Related Articles:


Recent Articles

Acadia CEO to Retire

The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia's Board of Directors and will assist in the selection and transition of the new CEO.

Read More

NEW FINDINGS FROM PRESS GANEY REVEAL MILLENNIAL NURSES ARE MOST LIKELY TO QUIT, AND NEARLY 30% OF NURSES ARE AT RISK OF LEAVING THEIR ORGANIZATION

Flight Risk Analysis of 100,000 U.S.-based healthcare workers underscores the importance of addressing the nurse staffing crisis

Read More

Research on Using Fluid Biomarkers to Advance Drug Treatments and Therapies for Alzheimer's, Traumatic Brain Injury, Concussion, and Other Neurodegene

New developments in the field of blood biomarkers for brain diseases including traumatic brain injury (TBI), and neurodegenerative diseases such as Alzheimer's, were unveiled during three lectures at the 25th Biennial World Congress of Neurology, October 3-7, 2021, and available virtually through the WCN 2021 portal.

Read More

Ataga Leading $3 Million AI Study For Predicting Kidney Function Decline in Sickle Cell Patients

Kenneth Ataga, MD, Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC), was recently awarded $3.2 million from the National Heart, Lung and Blood Institute for a project that enlists artificial intelligence in the fight against sickle cell disease.

Read More

Research Team Awarded $3 Million to Study Weight Loss, Bone Frailty Link in Diabetics

Two researchers in the Department of Preventive Medicine at the University of Tennessee Health Science Center have received a $3 million award from the National Institute on Aging to study why bones become more frail and prone to fracture in diabetics who achieve long-term weight loss.

Read More

AMA Publishes New Study Monitoring Competition in U.S. Health Insurance Markets

Twentieth edition of AMA study shows continued lack of competition

Read More

Grant Creates Center for Maternal, Pediatric Precision Therapeutics

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health (NIH) to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics (MPRINT).

Read More

Change in Respiratory Care Strategies for Preterm Infants Improves Health Outcomes

A decade's worth of data shows that neonatologists are shifting the type of respiratory support they utilize for preterm infants, a move that could lead to improved health outcomes.

Read More

The Fear of the Unknown: Anxiety and the Upcoming School Year

Nurture the Next Discusses Ways to Help Children Cope as they Return to School

Read More

Older Age, Chronic Co-Morbidities Associated with More Severe COVID Disease in Children

Over the course of the pandemic, researchers nationwide noticed differences in COVID-19 disease between children and adults.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: